{
     "PMID": "12470866",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20030327",
     "LR": "20141120",
     "IS": "0006-8993 (Print) 0006-8993 (Linking)",
     "VI": "958",
     "IP": "2",
     "DP": "2002 Dec 27",
     "TI": "Erythropoietin improves synaptic transmission during and following ischemia in rat hippocampal slice cultures.",
     "PG": "305-11",
     "AB": "Erythropoietin (EPO) prevents neuronal damage following ischemic, metabolic, and excitotoxic stress. In this study evoked extracellular field potentials (FP) were used to investigate the effect of EPO on synaptic transmission in hippocampal slice cultures. EPO treated cultured slices (40 units/ml for 48 h) showed significantly increased FP during and following oxygen and glucose deprivation compared with untreated control slices. The addition of the Jak2 inhibitor AG490 (50 microM for 48 h) blocked the EPO effect. These data suggest that EPO improves synaptic transmission during and following ischemia in hippocampal slice cultures.",
     "CI": [
          "Copyright 2002 Elsevier Science B.V."
     ],
     "FAU": [
          "Weber, Astrid",
          "Maier, Rolf F",
          "Hoffmann, Ulrike",
          "Grips, Martin",
          "Hoppenz, Marc",
          "Aktas, Ayse G",
          "Heinemann, Uwe",
          "Obladen, Michael",
          "Schuchmann, Sebastian"
     ],
     "AU": [
          "Weber A",
          "Maier RF",
          "Hoffmann U",
          "Grips M",
          "Hoppenz M",
          "Aktas AG",
          "Heinemann U",
          "Obladen M",
          "Schuchmann S"
     ],
     "AD": "Department of Neonatology, Charite, Humboldt University Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, D-13353 Berlin, Germany. astrid.weber@charite.de",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0 (Enzyme Inhibitors)",
          "0 (Proto-Oncogene Proteins)",
          "0 (Receptors, Erythropoietin)",
          "11096-26-7 (Erythropoietin)",
          "EC 2.7.10.1 (Protein-Tyrosine Kinases)",
          "EC 2.7.10.2 (Jak2 protein, rat)",
          "EC 2.7.10.2 (Janus Kinase 2)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Cell Hypoxia/drug effects/physiology",
          "Enzyme Inhibitors/pharmacology",
          "Erythropoietin/biosynthesis/*pharmacology",
          "Hippocampus/*drug effects/metabolism/physiology",
          "In Vitro Techniques",
          "Janus Kinase 2",
          "Protein-Tyrosine Kinases/antagonists & inhibitors/metabolism",
          "*Proto-Oncogene Proteins",
          "Rats",
          "Rats, Wistar",
          "Receptors, Erythropoietin/biosynthesis",
          "Synaptic Transmission/*drug effects/physiology"
     ],
     "EDAT": "2002/12/10 04:00",
     "MHDA": "2003/03/28 05:00",
     "CRDT": [
          "2002/12/10 04:00"
     ],
     "PHST": [
          "2002/12/10 04:00 [pubmed]",
          "2003/03/28 05:00 [medline]",
          "2002/12/10 04:00 [entrez]"
     ],
     "AID": [
          "S0006899302036041 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 2002 Dec 27;958(2):305-11.",
     "term": "hippocampus"
}